Geneticist Announces Congressional Bid

UC Berkeley researcher Michael Eisen says he will run for Senate in 2018.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, PLOSGeneticist Michael Eisen of the University of California, Berkeley, has been a vocal opponent of Donald Trump. Now, the researcher has announced his intent to run for US Senate. “We can't sit around and hope other people are going to solve our problems for us - time to step up, if you can…,” Eisen posted on his Twitter account on Sunday (January 29) after announcing his senate run last week (January 25).

“Too much of the scientific establishment looks at the government as a bank—that the primary thing we should worry about is can we get the right amount of money out of Congress,” Eisen told Science. “Too few people focus on the fact that science needs to be a partnership with the public for it to thrive.”

Eisen, who told Science that he plans to run as an independent, is perhaps the most recognizable name in a list of other scientists who are considering running for office to combat policies that seem broadly antagonistic to science. The groundswell is partly thanks to 314 Action, an organization run by chemist and former breast cancer researcher Shaughnessy Naughton, who ran for Congress in 2014 and 2016 but lost ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development